Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sihuan Pharmaceutical Hldgs (460 HK)
Watchlist
50
Analysis
Health Care
•
China
Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Nepstar Chain Drugstore
•
17 Mar 2016 18:00
Just What the Doctor Ordered
This is a quick update on Kemp Dolliver's previous insight "Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling...
Crispin Francis
300 Views
Share
bearish
•
Thematic (Sector/Industry)
•
10 Mar 2016 15:32
What Will China Look Like in 2025?
What will China look like in 2025? This is a follow up to our Outlook for China:10 Predictions for the Next 10 Years presentation, where we present...
Morningstar, Inc.
Follow
220 Views
Share
bearish
•
Thematic (Sector/Industry)
•
08 Mar 2016 11:20
Outlook for China:10 Predictions for the Next 10 Years
In this presentation, we present a series of data visualisations to back up 10 bold predictions we expect to play out in China over the next 10...
Morningstar, Inc.
Follow
230 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Feb 2016 05:38
Coming to the HKEX Soon....................
Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...
Kemp Dolliver, CFA
227 Views
Share
bullish
•
Thematic (Sector/Industry)
•
18 Feb 2016 23:01
Time to Go Shopping for Healthcare
The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...
Kemp Dolliver, CFA
250 Views
Share
First
Previous
6
7
8
9
10
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.42.3
x